Evidence map›Paper›PMID 32246196›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2020

A 2-year longitudinal study of neuropsychological functioning, psychosocial adjustment and rehospitalisation in schizophrenia and major depression.

Schaub Annette, Goerigk Stephan, Kim T Mueser, Hautzinger Martin, Roth Elisabeth, Goldmann Ulrich, Charypar Marketa, Engel Rolf, Möller Hans-Jürgen, Falkai Peter

Open access · hybridAbstract readComparative Study
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Schaub AnnetteDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Nussbaumstr.7, 80336, Munich, Germany. annette.schaub@med.uni-muenchen.de.
Goerigk StephanDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Nussbaumstr.7, 80336, Munich, Germany.
Kim T MueserCenter for Psychiatric Rehabilitation, Boston University, 940 Commonwealth Avenue, West Boston, MA, 02215, USA.
Hautzinger MartinDepartment of Clinical Psychology and Psychotherapy, University of Tübingen, 72026, Tübingen, Germany.
Roth ElisabethPrivate and Non-Private Praxis, 80333, Munich, Germany.
Goldmann UlrichDepartment of Psychology, Clinical Psychology and Psychotherapy, Ludwig Maximilian University of Munich, Leopoldstrasse 44, 80802, Munich, Germany.
Charypar MarketaJohannesbad Klinik, 93437, Furth im Wald, Germany.
Engel RolfDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Nussbaumstr.7, 80336, Munich, Germany.
Möller Hans-JürgenDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Nussbaumstr.7, 80336, Munich, Germany.
Falkai PeterDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Nussbaumstr.7, 80336, Munich, Germany.
Ludwig-Maximilians-Universität München · DEBoston University · USOrthopädische Praxis · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropsychological functioning turns out to be a rate-limiting factor in psychiatry. However, little is known when comparing neuropsychological and psychosocial functioning in inpatients with schizophrenia or severe depression in their treatment pathways including add-on psychoeducation or the latter combined with cognitive behavioral therapy up to 2-year follow-up. To evaluate this question, we investigated these variables in two randomised controlled trials including 196 patients with DSM-IV schizophrenia and 177 patients with major depression. Outcome measures were assessed in the hospital at pre- and posttreatment and following discharge until 2-year follow-up. We focused on neuropsychological and psychosocial functioning regarding its differences and changes over time in data of two pooled trials. There were significant time effects indicating gains in knowledge about the illness, short and medium-term memory (VLMT) and psychosocial functioning (GAF), however, the latter was the only variable showing a time x study/diagnosis interaction effect at 2-year follow-up, showing significant better outcome in depression compared to schizophrenia. Moderator analysis showed no changes in psychosocial and neuropsychological functioning in schizophrenia and in affective disorders due to age, duration of illness or sex. Looking at the rehospitalisation rates there were no significant differences between both disorders. Both groups treated with psychoeducation or a combination of psychoeducation and CBT improved in neuropsychological and psychosocial functioning as well as knowledge about the illness at 2-year follow-up, however, patients with major depression showed greater gains in psychosocial functioning compared to patients with schizophrenia. Possible implications of these findings were discussed.

Indexed as

Outcome Assessment, Health CarePatient ReadmissionSocial AdjustmentAdaptation, PsychologicalAdultAgedCognitive Behavioral TherapyCognitive DysfunctionEmotional AdjustmentFemaleHealth Knowledge, Attitudes, PracticeHumansLongitudinal StudiesMajor Depressive DisorderMaleMiddle AgedCognitive-behavioral therapyIllness managementMajor depressionNeuropsychological functioningPsychoeducationPsychosocial functioningRehospitalisation rateSchizophrenia

Identifiers

PMID32246196
PMCPMC7423783
OpenAlexW3014519028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.